Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome
about
Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile womenPolycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age WomenDyslipidemia in women with polycystic ovary syndromeScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India.Metabolic phenotype in the brothers of women with polycystic ovary syndrome.The role of the polycystic ovary syndrome susceptibility locus D19S884 allele 8 in maternal glycemia and fetal sizeThe American Diabetes Association's 57th annual advanced postgraduate course: diabetes risk, vitamin D, polycystic ovary syndrome, and obstructive sleep apnea.Prenatal androgen treatment alters body composition and glucose homeostasis in male ratsBirth weight and childhood growth in daughters of women with irregular menstrual cycles.State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).The metabolic syndrome in women.Ovarian hypertension: polycystic ovary syndrome.Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters.Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndromeThe metabolic syndrome in polycystic ovary syndrome.Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohortsHyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled studyThe role of genetic variation in the lamin a/c gene in the etiology of polycystic ovary syndrome.Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndromeBrothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects.Metabolic Syndrome and Its Characteristics among Reproductive-Aged Women with Polycystic Ovary Syndrome: A Cross-sectional Study in Northwest IranHigh prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity.The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.The role of family history in clinical symptoms and therapeutic outcomes of women with polycystic ovary syndrome.The role of opioid system and its interaction with sympathetic nervous system in the processing of polycystic ovary syndrome modeling in rat.Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.Metabolic and reproductive characteristics of first-degree relatives of women with self-reported oligo-amenorrhoea and hirsutism
P2860
Q24234635-87D2FF10-7745-40EF-A211-5FBB767B1CD3Q27021307-303DFEA7-9FC0-48C3-97D6-BDBEE907CF12Q27025695-B1A17A34-F69B-4879-850D-88E48DAE2A77Q28390200-8A5C477E-1AA6-4983-91FA-FDF5348FBAC5Q30440354-87DF70A7-0126-43FE-9BED-F9C4AB00CB0EQ33569169-C997A5A4-BC72-4D15-BFD4-7B7D29922D05Q33750469-B2A48133-502C-497B-8E2F-AF7F53001DF3Q33962557-BBF2F98D-3149-44BE-9B2A-7F0A6C150E4AQ34086652-5FBB6E67-81DE-4BA8-A6DE-85E3D4ED7B6FQ34421903-3043053D-727D-455C-B1D2-CD1D93260222Q34574446-4EDAAFC9-342F-46F1-97F9-140C909544B4Q35137230-23B987EA-4F89-4410-9058-852AEB029221Q35233754-3FFF2077-8FEA-49F8-A745-6793253B04A6Q35597000-B41B0AA6-5FFC-4DBB-A8CF-1EC04FBA13F1Q35660296-BD37DA12-8F71-4DEA-A99E-719EB7B6BC9AQ36222973-AAF80415-E89B-4EC4-B1A2-F1844E6D2A46Q36334951-31BF4BA3-EB2F-4EC5-B83D-26D80DDB2EE4Q36472269-447B62D5-1706-42D1-8CE5-9714CF087528Q36507128-636C1702-375C-4265-9D82-783C6DB58568Q36661975-B0DB28AB-E79E-4FAF-9CC3-336D536E99C5Q37257568-27DD64C6-370B-4AF6-832A-D67891E1A2CFQ37257592-E40CC919-5738-4AEA-A964-EB88BC19A759Q37262330-8D9D3FD9-313A-4480-87D2-B9BDE96E354BQ37355732-9500FB00-478D-4C49-B3E9-8E3F6E4D2598Q37362881-33014B85-7E13-42A6-8847-221002772355Q37417433-51B1ED5F-2CC3-4907-B7D3-26692C67D3C5Q41640666-B24C92AC-1604-40DB-8337-B88DEE0CFB56Q43274280-8767B7FC-BCEA-4024-BC90-5C524425681DQ44348594-B2429F15-C171-47EE-97D1-8F0A3AA0593EQ50056205-AD665BDB-13DD-4566-9AF8-067C48EF6630Q57118806-16C5E405-D8E4-458A-AC13-AD4BFF03B6E9
P2860
Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Dyslipidemia and metabolic syn ...... with polycystic ovary syndrome
@ast
Dyslipidemia and metabolic syn ...... with polycystic ovary syndrome
@en
type
label
Dyslipidemia and metabolic syn ...... with polycystic ovary syndrome
@ast
Dyslipidemia and metabolic syn ...... with polycystic ovary syndrome
@en
prefLabel
Dyslipidemia and metabolic syn ...... with polycystic ovary syndrome
@ast
Dyslipidemia and metabolic syn ...... with polycystic ovary syndrome
@en
P2093
P2860
P921
P356
P1476
Dyslipidemia and metabolic syn ...... with polycystic ovary syndrome
@en
P2093
Andrea Dunaif
Rhonda Bentley-Lewis
Richard S Legro
P2860
P304
P356
10.1210/JC.2004-2217
P407
P577
2005-05-17T00:00:00Z